Skip to content
DraconiticResearch
Search Sources API
193,349 studies31 sourcesUpdated 15 min ago
Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer

1076 Patient-derived organoids reveal tumor-restricted noncanonical HLA-I antigen candidates in low mutation burden metastatic melanoma

  • David Scheinberg1
  • Chenyang Zhan2
  • Wilson H McKerrow1
  • Benjamin D Greenbaum1
  • Mara Monetti1
  • Alexander N Shoushtari1
  • James W Smithy1
  1. 1Memorial Sloan Kettering Cancer Center, New York, NY, USA
  2. 21 Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Open at sourcePDFDOICite

Related

  1. Impacts of mutation accumulation and order on tumor initiation revealed by engineered murine colorectal cancer organoids
    Yanping Li, Xiaoxin Xie, Daqi Deng +6
    eLifePeer-reviewedCC BY 4.0Full textOncologyeLifeEurope PMCPMC
  2. Metastatic founder cell candidates resemble preimplantation embryonic blastomeres
    C. A. Klein, H. Koerkel-Qu, E. Raya +22
    bioRxivPreprintCC BYFull textOncologybioRxiv
  3. Case Report: Lenvatinib plus osimertinib treated a metastatic hilar cholangiocarcinoma patient harboring EGFR mutation
    Peng Wang, Chentao Zou, Wendi Liu +4
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaCrossref
  4. Garsorasib (D-1553) in Combination With Pembrolizumab and Chemotherapy for First-Line Metastatic NSCLC With KRAS G12C Mutation: Results of a Phase 1b Study.
    Dong Yan, Chaoying Liu, Xingya Li +10
    JTO clinical and research reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  5. Efficacy and safety of immune checkpoint inhibitors combined with TKIs for recurrent or metastatic cervical cancer with PIK3CA mutation
    Lele Chang, Yaxin Kang, Mingxuan Zhu +3
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS

Cite

BibTeXRIS
BibTeX
@article{scheinberg20261076,
  title = {{1076 Patient-derived organoids reveal tumor-restricted noncanonical HLA-I antigen candidates in low mutation burden metastatic melanoma}},
  author = {David Scheinberg and Chenyang Zhan and Wilson H McKerrow and Benjamin D Greenbaum and Mara Monetti and Alexander N Shoushtari and James W Smithy},
  journal = {Journal for ImmunoTherapy of Cancer},
  year = {2026},
  month = nov,
  doi = {10.1136/jitc-2026-sitc2026.1076},
  url = {https://doi.org/10.1136/jitc-2026-sitc2026.1076},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - 1076 Patient-derived organoids reveal tumor-restricted noncanonical HLA-I antigen candidates in low mutation burden metastatic melanoma
AU  - David Scheinberg
AU  - Chenyang Zhan
AU  - Wilson H McKerrow
AU  - Benjamin D Greenbaum
AU  - Mara Monetti
AU  - Alexander N Shoushtari
AU  - James W Smithy
PY  - 2026
DA  - 2026/11/04
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2026-sitc2026.1076
UR  - https://doi.org/10.1136/jitc-2026-sitc2026.1076
SN  - 2051-1426
ER  -